Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors >5 BU.

AJBR showed a nonsignificant trend of increased bleeding for those with the highest inhibitor titers.

also in 5,406 other papers

Findings for BPA prophylaxis showed no reduction in ABR or AJBR for rFVIIa prophylaxis (generally administered 3 times per week) during ITI but showed a trend toward ABR reduction (adjusted hazard ratio [aHR], 0.68) and a significant AJBR reduction (aHR, 0.37; 95% CI, 0.18-0.77) for aPCC prophylaxis, which was administered twice daily for majority of the patients.

also in 53,322 other papers